Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05147922 · ClinicalTrials.gov registry record · NA
Neo RQI: The Effect of Neonatal Resuscitation Quality Improvement Cart Booster Training Skills Retention
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 155
- Enrollment target
NCT05147922: Completed NA study, sponsored by University of Texas Southwestern Medical Center.
NCT05147922 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 155 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05147922, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
Study Summary
This is a prospective multicenter randomized control trial to assess percentage mask leak six months post instructor led positive pressure ventilation skills training in providers who undergo booster training compared to those who do not undergo any booster training
Primary Outcome
The primary outcome of the study is the proportion of subjects who provide \>80% ventilation with low mask leak (\< 30% mask leak) during the one-minute assessment at six months from the instructor led positive pressure ventilation skills training
Interventions
- BEHAVIORAL Booster Training with the Neonatal Resuscitation Quality Improvement Cart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT05147922 record still lists
NCT05147922 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Booster Training with the Neonatal Resuscitation Quality Improvement Cart is the first listed.
NCT05147922 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05147922 about?
NCT05147922 is a clinical study titled "Neo RQI: The Effect of Neonatal Resuscitation Quality Improvement Cart Booster Training Skills Retention". This is a prospective multicenter randomized control trial to assess percentage mask leak six months post instructor led positive pressure ventilation skills training in providers who undergo booster training compared to those who do not undergo any booster training
What is the current status of trial NCT05147922?
This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2022-04-18. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05147922?
The interventions under investigation include: Booster Training with the Neonatal Resuscitation Quality Improvement Cart (BEHAVIORAL).
Who is sponsoring clinical trial NCT05147922?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05147922's enrollment target sits among peer trials
155 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI